In vivo and in vitro effects of carbenoxolone on glucocorticoid receptor binding and glucocorticoid activity

Steroids

Volumn 62, Issue 4, 1997, Pages 388-394

  Soro, A ^a,b   Panarelli, M ^a,c   Holloway, C D ^a   Fraser, R ^a   Kenyon, C J ^a,d  

^a WESTERN INFIRMARY   (United Kingdom)

^b UNIVERSITY OF SASSARI   (Italy)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

11 hydroxysteroid dehydrogenase; carbenoxolone; corticosterone; dexamethasone; glucocorticoid receptor

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CARBENOXOLONE; CORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLYCYRRHIZIC ACID; HYDROCORTISONE; MINERALOCORTICOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BLOOD PRESSURE; COMPETITIVE INHIBITION; CONTROLLED STUDY; HORMONE ACTION; MALE; NEGATIVE FEEDBACK; NONHUMAN; RAT; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; WEIGHT GAIN;

ANIMALS; ANTI-ULCER AGENTS; BINDING, COMPETITIVE; BLOOD PRESSURE; CARBENOXOLONE; CORTICOSTERONE; CYTOSOL; DEXAMETHASONE; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; WEIGHT GAIN;

ANIMALIA;

EID: 0030988986     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(96)00252-8     Document Type: Article

References (29)

1. Stewart PM, Wallace AM, Atherden SM, Shearing CH, Edwards CRW (1990). Mineralocorticoid activity of carbenoxolone: Contrasting effects of carbenoxolone and liquorice on 11β-hydroxysteroid dehydrogenase activity in man. Clin Sci 78:49-54.
2. Walker BR, Connacher AA, Webb DJ, Edwards CRW (1992). Glucocorticoids and blood pressure: A role for the cortisol/cortisone shuttle in the control of vascular tone in man. Clin Sci 83:171-178.
3. Gaeggeler H -P, Edwards CRW, Rossier BC (1989). Steroid metabolism determines mineralocorticoid specificity in the toad bladder. Am J Physiol 257:F690-F695.
4. Souness GW, Morris DJ (1989). The antinatriuretic and kaliuretic effects of the glucocorticoids corticosterone and cortisol following pre-treatment with carbenoxolone sodium (a liquorice derivative) in the adrenalectomized rat. Endocrinology 124:1588-1590.
5. Monder C, Stewart PM, Lakshmi V, Valentino R, Burt D, Edwards CRW (1989). Licorice inhibits corticosteroid 11β-dehydrogenase of rat kidney and liver: In vivo and in vitro studies. Endocrinology 125:1046-1053.
6. Latif SA, Semafuko SEB, Morris DJ (1992). Effects of carbenoxolone administered acutely to adrenalectomized rats (in vivo) on renal and hepatic handling of corticosterone by 11β-hydroxysteroid dehydrogenase. Steroids 55:52-58.
7. Ulick S, Wang JZ, Hanukoglu A, Rosler A (1993). The effect of carbenoxolone on the peripheral metabolism of cortisol in human patients. J Lab Clin Med 122:673-676.
8. Kenyon CJ, Fraser R (1992). Biochemistry of steroid, hypertension. In: James VHT (ed), The Adrenal Cortex (2nd ed). Raven Press, New York, pp. 241-262.
9. Walker BR, Sang KS, Williams BC, Edwards CRW (1994). Direct and indirect effects of carbenoxolone on responses to glucocorticoids and noradrenaline in rat aorta. J Hypertension 12:33-39.
10. Mercer WR, Krozowsky Z (1992). Localization of an 11β-hydroxysteroid dehydrogenase activity to the distal nephron. Evidence for the existence of two species of dehydrogenase in the rat kidney. Endocrinology 130:540-543.
11. Naraj-Fejes-Toth A, Watlington CO, Fejes-Toth G (1991). 11β-hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone. Endocrinology 129:17-21.
12. Brown RW, Chapman KE, Edwards CRW, Seckl JR (1993). Human placental 11β-hydroxysteroid dehydrogenase: Evidence for a partial purification of a distinct NAD+-dependent isoform. Endocrinology 132:2614-2621.
13. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS (1994). Cloning and tissue distribution of human 11β-hydroxysteroid dehydrogenase type 2 enzymes. Mol Cell Endocrinol 105:R11-R17.
14. Walker BR, Connacher AA, Lindsay RM, Webb DJ, Edwards CRW (1995). Carbenoxolone increases hepatic insulin sensitivity in man: A novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocr Metab 80:3155-3159.
15. Armanini D, Karbowiak I, Krozowski Z, Funder JW, Adam WR (1982). The mechanism of mineralocorticoid action of carbenoxolone. Endocrinology 111:1683-1686.
16. Armanini D, Karbowiak I, Funder JW (1983). Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors. Clin Endocrinol 19:609-612.
17. Ormsbee HS, Ryan CF (1973). Production of hypertension with deoxycorticosterone acetate-impregnated silicone rubber implants. J Pharm Sci 62:255-257.
18. Evans AL, Brown W, Kenyon CJ, Maxted KJ, Smith DC (1994). An improved system for measuring systolic blood pressure in the conscious rat. Med Biol Eng Comput 32:101-102.
19. Kenyon CJ, Panarelli M, Holloway CD, Dunlop D, Morton JJ, Connell JMC, Fraser R (1993). The role of glucocorticoid activity in the inheritance of hypertension: Studies in the rat, J Steroid Biochem Mol Biol 45:7-11.
20. Morton JJ, Wallace ECH (1983). The importance of the renin angiotensin system in the development and maintenance of hypertension in the two-kidney, one-clip hypertensive rat. Clin Sci 64:483-484.
21. Munson PJ, Rodbard D (1980). Ligand: A versatile computerized approach for characterisation of ligand-binding systems. Anal Biochem 107:220-229.
22. Panarelli M, Holloway CD, Barr ABP, Fraser R, Kenyon CJ (1995). Differences in temperature-sensitive receptor binding of glucocorticoids in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Steroids 60:73-75.
23. Haynes RC (1992). Adrenocorticotropic hormone; adrenocorticosteroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Goodman-Gilman A, Rall TW, Nies AS, Taylor P (eds), The Pharmacological Basis of Therapeutics (8th ed). Macmillan, New York, Toronto, pp. 1431-1462.
24. Tonolo G, Fraser R, Connell JMC, Fraser R (1988). Chronic low dose infusions of dexamethasone in rats: Effects on blood pressure, body weight and plasma atrial natriuretic peptide, J Hypertension 6:25-31.
25. Dallman MF, Levin N, Cascio CS, Akana SF, Jacobson L, Kuhn RW (1989). Pharmacological evidence that the inhibition of diurnal adrenocorticotropin secretion by corticosteroids is mediated via type 1 corticosterone preferring receptors. Endocrinology 124:2844-2850.
26. Kalinyak JE, Dorin RI, Hoffman AR, Perlman AJ (1987). Tissue-specific regulation of glucocorticoid receptor mRNA by dexamethasone. J Biol Chem 262:1041-1044.
27. Ulman A, Menard J, Corvol P (1975). Binding of glycyrrhetinic acid to kidney mineralocorticoid and glucocorticoid receptors. Endocrinology 97:46-51.
28. Baron DN, Green RJ (1986). Action of compounds with effective in vivo mineralocorticoid activity on ion transport in leucocytes. Brit J Clin Pharmacol 21:27-34.
29. Gomez-Capilla JA, Gutierrez C, Fernandez-Fernandez JM (1988). Effect of carbenoxolone on glucose metabolism in rat adipose tissue. Biochem Pharmacol 37:1299-1301.